Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caitlin A Madison

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Psychological Medicine|March 25, 2020
Buprenorphine: prospective novel therapy for depression and PTSDCaitlin A Madison, Shoshana Eitan
Neuroscience and Biobehavioral Reviews|April 24, 2021
The self-serving benefits of being a good host: A role for our micro-inhabitants in shaping opioids' functionShoshana Eitan, Caitlin A Madison, Jacob Kuempel
Behavioural Pharmacology|March 14, 2020
Response to opioids is dependent on sociability levelsCaitlin A Madison, Paul J Wellman, Shoshana Eitan
Journal of Psychopharmacology (Oxford, England)|June 4, 2020
Pre-exposure of adolescent mice to morphine results in stronger sensitization and reinstatement of conditioned place preference than pre-exposure to hydrocodoneCaitlin A Madison, Paul J Wellman, Shoshana Eitan
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 11, 2022
Blood-brain barrier crossing using magnetic stimulated nanoparticlesJingfan Chen, Muzhaozi Yuan, Caitlin A Madison, et al.
ACS Chemical Neuroscience|June 4, 2020
Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in MiceCaitlin A Madison, Meenakshi Arora, M N V Ravi Kumar, et al.
Journal of Affective Disorders|April 21, 2023
Selective aryl hydrocarbon receptor modulators can act as antidepressants in obese female miceRoanna A Debler, Caitlin A Madison, Lauren Hillbrick, et al.
Behavioural Pharmacology|December 11, 2024
1,4-dihydroxy-2-naphthoic acid prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced motor function deficitsCaitlin A Madison, Roanna A Debler, Paula L Gallegos, et al.
Journal of Affective Disorders|April 24, 2022
3,3'-Diindolylmethane and 1,4-dihydroxy-2-naphthoic acid prevent chronic mild stress induced depressive-like behaviors in female miceCaitlin A Madison, Jacob Kuempel, Georgia Lee Albrecht, et al.
Journal of Affective Disorders|October 7, 2022
Sex-dependent differences in the stress mitigating and antidepressant effects of selective aryl hydrocarbon receptor modulatorsCaitlin A Madison, Roanna A Debler, Nathan I Vardeleon, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Psychological Medicine|March 25, 2020
Buprenorphine: prospective novel therapy for depression and PTSDCaitlin A Madison, Shoshana Eitan
Neuroscience and Biobehavioral Reviews|April 24, 2021
The self-serving benefits of being a good host: A role for our micro-inhabitants in shaping opioids' functionShoshana Eitan, Caitlin A Madison, Jacob Kuempel
Behavioural Pharmacology|March 14, 2020
Response to opioids is dependent on sociability levelsCaitlin A Madison, Paul J Wellman, Shoshana Eitan
Journal of Psychopharmacology (Oxford, England)|June 4, 2020
Pre-exposure of adolescent mice to morphine results in stronger sensitization and reinstatement of conditioned place preference than pre-exposure to hydrocodoneCaitlin A Madison, Paul J Wellman, Shoshana Eitan
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 11, 2022
Blood-brain barrier crossing using magnetic stimulated nanoparticlesJingfan Chen, Muzhaozi Yuan, Caitlin A Madison, et al.
ACS Chemical Neuroscience|June 4, 2020
Novel Oral Nanoparticle Formulation of Sustained Release Naloxone with Mild Withdrawal Symptoms in MiceCaitlin A Madison, Meenakshi Arora, M N V Ravi Kumar, et al.
Journal of Affective Disorders|April 21, 2023
Selective aryl hydrocarbon receptor modulators can act as antidepressants in obese female miceRoanna A Debler, Caitlin A Madison, Lauren Hillbrick, et al.
Behavioural Pharmacology|December 11, 2024
1,4-dihydroxy-2-naphthoic acid prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced motor function deficitsCaitlin A Madison, Roanna A Debler, Paula L Gallegos, et al.
Journal of Affective Disorders|April 24, 2022
3,3'-Diindolylmethane and 1,4-dihydroxy-2-naphthoic acid prevent chronic mild stress induced depressive-like behaviors in female miceCaitlin A Madison, Jacob Kuempel, Georgia Lee Albrecht, et al.
Journal of Affective Disorders|October 7, 2022
Sex-dependent differences in the stress mitigating and antidepressant effects of selective aryl hydrocarbon receptor modulatorsCaitlin A Madison, Roanna A Debler, Nathan I Vardeleon, et al.
Pageof 2